Physician profile
James Cole
NPI 1467570028
$567.89
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $141 · 2021: $59.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $345.07 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $51.54 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $48.92 | 2019 | |
| Pfizer INC. | $39.88 | 2019 | |
| Scilex Pharmaceuticals INC. | $31.31 | 2019-2021 | |
| Horizon Therapeutics Plc | $22.73 | 2020 | |
| Biodelivery Sciences International, INC. | $17.37 | 2019 | |
| Daiichi Sankyo INC. | $11.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.